South San Francisco, CA May 25, 2017 Genentech Press Release Actemra® is the first FDA-approved treatment for adults with giant cell arteritis (GCA) FDA previously granted Priority Review and Breakthrough Therapy Designation for Actemra in GCA Sixth FDA…